Pravachol, Pravastatin

Pravachol, Pravastatin Newswire

Comprehensive Real-Time News Feed for Pravachol, Pravastatin (generic).

Results 1 - 20 of 58 in Pravachol, Pravastatin (generic)

  1. Use of cholesterol-lowering meds on the riseRead the original story w/Photo

    23 hrs ago | Fox News

    The percentage of Americans taking medication to control their cholesterol has risen by a third over the past decade, a new study finds. In 2012, the percentage of people ages 40 and over who said they had used a cholesterol-lowering medication in the past month was 28 percent, up from 20 percent in 2003, according to the report from the Centers for Disease Control and Prevention.

    Comment?

  2. Mixing clarithromycin with statins could lead to hospitalizationRead the original story w/Photo

    Tuesday | Medical News Today

    The antibiotic clarithromycin and cholesterol-lowering statins are some of the most widely prescribed drugs in the world. New research, however, has found that certain combinations of the two could increase the risk of adverse events and, in certain cases, could lead to hospitalization.

    Comment?

  3. Certain Antibiotic/Statin Combos May Be Unsafe MixRead the original story w/Photo

    Monday Dec 22 | MedlinePlus

    Seniors who take the antibiotic Biaxin along with certain types of cholesterol-lowering statins are at risk for drug interaction side effects that can lead to hospitalization or even death, a new study suggests. "Physicians need to be made aware of this newly described dangerous interaction and consider alternative antibiotics to prevent toxicity that could be life-threatening," said expert Dr. Kevin Marzo, chief of cardiology at Winthrop-University Hospital in Mineola, N.Y. He was not involved in the new study, which appears in the Dec. 22 issue of the Canadian Medical Association Journal .

    Comment?

  4. Use of Cholesterol-Lowering Meds on the RiseRead the original story w/Photo

    Monday | LiveScience

    The percentage of Americans taking medication to control their cholesterol has risen by a third over the past decade, a new study finds. In 2012, the percentage of people ages 40 and over who said they had used a cholesterol-lowering medication in the past month was 28 percent, up from 20 percent in 2003, according to the report from the Centers for Disease Control and Prevention.

    Comment?

  5. Clarithromycin Plus Certain Statins Associated with Hospitalization Risk in Older AdultsRead the original story

    Monday | Journal Watch

    Using Canadian healthcare databases, researchers examined records of 100,000 patients aged 66 and older who were taking statins not metabolized by CYP3A4 and who also received a prescription for either clarithromycin or azithromycin. Clarithromycin inhibits OATP1B1 and OATP1B3, but azithromycin does not.

    Comment?

  6. Statin-Antibiotic Combination Can Be DeadlyRead the original story w/Photo

    Monday Dec 22 | News Max

    Seniors who take the antibiotic Biaxin along with certain types of cholesterol-lowering statins are at risk for drug interaction side effects that can lead to hospitalization or even death, a new study suggests. "Physicians need to be made aware of this newly described dangerous interaction and consider alternative antibiotics to prevent toxicity that could be life-threatening," said expert Dr. Kevin Marzo, chief of cardiology at Winthrop-University Hospital in Mineola, N.Y. He was not involved in the new study, which appears in the Dec. 22 issue of the Canadian Medical Association Journal .

    Comment?

  7. Clarithromycin-statin mix can cause drug interactions, requiring hospitalizationRead the original story w/Photo

    Monday Dec 22 | Science Daily

    The combination of the common antibiotic clarithromycin with some statins increases the risk of adverse events, which may require hospital admission for older people, according to a new study. Statins, used to lower cholesterol, are one of the most widely prescribed drugs, with projections estimated at more than 1 billion people around the globe.

    Comment?

  8. Using Bayesian-PBPK modeling for assessment of inter-individual...Read the original story

    Friday Dec 19 | CiteULike

    Inter-individual variability in clinical endpoints and occurrence of potentially severe adverse effects represent an enormous challenge in drug development at all phases of clinical research. To ensure patient safety it is important to identify adverse events or critical subgroups within the population as early as possible.

    Comment?

  9. Early statin use may give long-term heart benefitsRead the original story w/Photo

    Sunday Dec 14 | Crescent-News.com

    Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds.

    Comment?

  10. Early statin use may give long-term heart benefitsRead the original story

    Monday Nov 24 | The Star

    Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds. Doctors say it's the first evidence that early use of a statin can have a legacy effect, perhaps changing someone's odds of disease for good.

    Comment?

  11. Web-scale pharmacovigilance: listening to signals from the crowdRead the original story

    Nov 21, 2014 | CiteULike

    Adverse drug events cause substantial morbidity and mortality and are often discovered after a drug comes to market. We hypothesized that Internet users may provide early clues about adverse drug events via their online information-seeking.

    Comment?

  12. Scottish study shows heart benefit of the use of statins earlier in lifeRead the original story w/Photo

    Nov 20, 2014 | South China Morning Post

    Taking a cholesterol-lowering drug for five years in middle age could lower heart and death risks for decades, and the benefits seemed to grow over time, a study in Scotland has found. Doctors have said it was the first evidence that early use of a statin could have a legacy effect, perhaps permanently changing someone's odds of disease.

    Comment?

  13. Early statin use may give long-term heart benefitsRead the original story w/Photo

    Nov 20, 2014 | Daily Herald

    Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds. Doctors say it's the first evidence that early use of a statin can have a legacy effect, perhaps changing someone's odds of disease for good.

    Comment?

  14. Using statin early can help heart for decades to comeRead the original story w/Photo

    Nov 20, 2014 | The Times-Tribune

    Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds. Doctors say it's the first evidence that early use of a statin can have a legacy effect, perhaps changing someone's odds of disease for good.

    Comment?

  15. Early statin use may give long-term heart benefitsRead the original story

    Nov 19, 2014 | The Times Bulletin

    Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds. Doctors say it's the first evidence that early use of a statin can have a legacy effect, perhaps changing someone's odds of disease for good.

    Comment?

  16. Use of cholesterol drug in middle age lowers heart risks for decades later, study findsRead the original story w/Photo

    Nov 19, 2014 | Canada.com

    Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds. Doctors say it's the first evidence that early use of a statin can have a legacy effect, perhaps changing someone's odds of disease for good.

    Comment?

  17. Dr. Roach: Metal joins in MRIL sleuthing safetyRead the original story w/Photo

    Oct 26, 2014 | SouthCoastToday.com

    DEAR DR. ROACH: I am considering minimally invasive spine surgery. Almost 19 years ago, I had a right total-knee replacement, which still functions very well.

    Comment?

  18. Hormone replacement therapy and statins: what every woman should knowRead the original story w/Photo

    Oct 23, 2014 | Examiner.com

    The objective of the study was to examine the effects of HRT on the risk of cardiovascular outcomes and all-cause mortality in women treated with statins In their menopausal years, many women take statins and/or hormone replacement therapy . A new study evaluated the use of HRT and cardiovascular risk among women under treatment with statins.

    Comment?

  19. Generic Drug Makers Under Fire From Congress Over Skyrocketing PricesRead the original story w/Photo

    Oct 9, 2014 | ShoppingBlog.com

    The cost of generic prescription medications has been soaring in the past year. Because approximately 86% of all drugs dispensed today are generics rather than name brands, the rising cost of generic medications is making needed medicines out of reach for many Americans and putting independent pharmacies at risk of going out of business.

    Comment?

  20. Health Highlights: Oct. 8, 2014Read the original story

    Oct 8, 2014 | HON

    Congress has launched an investigation into huge increases in the prices of 10 generic drugs that prompted complaints from consumers and pharmacists. Lawmakers want generic drug makers to explain the reasons for the large price hikes in generic drugs -- the cost of some has climbed more than 1,000 percent in the last year -- or possibly face new regulations, The New York Times reported.

    Comment?